Nalaganje...
A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. Repurposing of approved pharmaceutical drugs for COVID-19 treatment represents an attractive approach to quickly identify promising drug candidates. SARS-...
Shranjeno v:
| izdano v: | J Biomol Struct Dyn |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7597227/ https://ncbi.nlm.nih.gov/pubmed/33094680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1837680 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|